SiteOne Therapeutics

Healthcare & Life Sciences

Recent Finacing

Series C

Recent Raise

$100M

SiteOne Therapeutics is a biopharmaceutical company developing selective, small molecule ion channel modulators for treating sensory hyperexcitability disorders like pain and chronic cough.

Total Funding

$100M

Headquarters

South San Francisco, USA

Founded

N/A

Website

siteonetherapeutics.com

Focus Areas

Biopharmaceutical

Ion Channel Modulators

Sensory Hyperexcitability

Non-Opioid Pain Therapeutics

Sodium Channels

Pain Relief

Investors